Oncologia de Cap i Coll i ORL (GROCC)

ONCOLOGIA
OBJECTIUS

El Grup de recerca en oncologia de cap i coll pretén avançar en el coneixement de les malalties tumorals d’aquesta àrea anatòmica que comprèn el coll, la  boca, la llengua, la faringe, la laringe, les fosses nasals i les glàndules salivals, ja sigui en l’àmbit molecular, translacional i clínic, així com de desenvolupament de tècniques i dispositius quirúrgics. La nostra visió és donar resposta a les qüestions que es plantegen quan estem davant dels pacients, per aquest motiu els metges que treballen a l’hospital treballen amb investigadors bàsics. La complexitat, la referència, la recerca i la docència són la base d’aquest grup de recerca.

RESPONSABLES
  • Dr. F. Xavier Avilés Jurado

  • Línies de recerca
  • Membres del grup
  • Projectes
  • Publicacions
  • Difusió
  • Contacte
  • Factors pronòstics derivats del metabolisme del càncer de cap i coll
  • Abordatges quirúrgics mínimament invasius
  • Caracterització multiòmica del càncer de cap i coll
  • Introducció de biòpsies en matrius mínimament invasives

  • Caracterización multiómica del carcinoma escamoso de cabeza y cuello mediante biopsia gaseosa y líquida: aplicación diagnóstica, pronóstica y de seguimiento. HN-OMICS. Proyectos de investigación de medicina personalizada. Ministerio Ciencia e Innovación. Grupo coordinador.2023-2026. 929.500eur

  • Microbiota tumor metabolic regulation as prognostic factors in HNSCC. Entitat finançadora: AECC-Asociación española contra el cáncer: 253.000 eur. 2019-2022

  • Microbiota y alteraciones metabólicas como factor pronóstico en el carcinoma escamoso de cabeza y cuello. FIS PI18/00844ISC3 – Instituto de Salud Carlos III 111.320 eur. 2019-2021

  • Impacto clínico del metabolismo de la glucosa en el carcinoma escamoso de cabeza y cuello. FIS PI15/02047. Instituto de Salud Carlos III. 75.000eur

  • Grup recerca emergent Head Neck Clínic. Agència de Gestió d’Ajuts Universitaris i de Recerca (AGAUR): 2017 SGR 5081. 9.950eur. 2017-2021

    Prognostic capacity of the transcriptional expression of lactate dehydrogenase A in patients with head and neck squamous cell carcinoma.

    Bagué S, León X, Terra X, Lejeune  , Camacho M, Avilés-Jurado FX. Head Neck. 2022 Nov;44(11):2505-2512. Epub 2022 Aug 4. PMID: 36207788

    DOI: 10.1002/hed.27161

    Sinonasal mucosal melanomas: defining profiles for better survival outcomes.

    Rojas-Lechuga MJ, Gras-Cabrerizo JR, Aviles-Jurado FX, Malvehy J, Arance AM, Castillo P, Barreiro A, Podlipnik S, Lopez-Chacon M, Alobid I, Bernal Sprekelsen M, Puig S, Langdon C. Rhinology. 2022 Oct 1;60(5):347-356. PMID: 36184882

    DOI: 10.4193/Rhin21.251

    Persistent lymph nodes after curative chemoradiotherapy for head and neck cancer: imaging predictors of response for decision-making.

    Páez-Carpio A, Medrano-Martorell S, Berenguer J, Muxí A, Vilaseca I, Valduvieco I, Castillo P, Baste N, Avilés-Jurado FX, Grau JJ, Oleaga L. Eur Arch Otorhinolaryngol. 2022 Oct 1. Online ahead of print. PMID: 36181529

    DOI: 10.1007/s00405-022-07658-3

    Semaphorin-3F/Neuropilin-2 Transcriptional Expression as a Predictive Biomarker of Occult Lymph Node Metastases in HNSCC.

    Meler-Claramonte C, Avilés-Jurado FX, Vilaseca I, Terra X, Bragado P, Fuster G, León Vintró X, Camacho M. Cancers (Basel). 2022 Apr 30;14(9):2259. PMID: 35565388 Free PMC article.

    DOI: 10.3390/cancers14092259

    Predictive capacity of IL-8 expression in head and neck squamous carcinoma patients treated with radiotherapy or chemoradiotherapy.

    León X, García J, Farré N, Majercakova K, Avilés-Jurado FX, Quer M, Camacho M. Acta Otorrinolaringol Esp (Engl Ed). 2021 Nov-Dec;72(6):337-343. PMID: 34844671

    DOI: 10.1016/j.otoeng.2020.05.006

    Transoral laser microsurgery in locally advanced laryngeal cancer: Prognostic impact of anterior versus posterior compartments.

    Vilaseca I, Aviles-Jurado FX, Valduvieco I, Berenguer J, Grau JJ, Baste N, Muxí Á, Castillo P, Lehrer E, Jordana M, Ramírez-Ruiz RD, Costa JM, Oleaga L, Bernal-Sprekelsen M. Head Neck. 2021 Dec;43(12):3832-3842. Epub 2021 Sep 27. PMID: 34569120

    DOI: 10.1002/hed.26878

    Timing of elective tracheotomy and duration of mechanical ventilation among patients admitted to intensive care with severe COVID-19: A multicenter prospective cohort study.

    Prats-Uribe A, Tobed M, Villacampa JM, Agüero A, García-Bastida C, Tato JI, Rodrigáñez L, Holguera VD, Hernández-García E, Poletti D, Simonetti G, Villarraga V, Meler-Claramonte C, Sánchez Barrueco Á, Chiesa-Estomba C, Casasayas M, Parente-Arias P, Mata-Castro N, Rello J, Castro P, Prieto-Alhambra D, Vilaseca I, Avilés-Jurado FX; TraqueoCOVID SEORL Group. Head Neck. 2021 Dec;43(12):3743-3756. PMID: 34524714

    DOI: 10.1002/hed.26863

    Succinate Pathway in Head and Neck Squamous Cell Carcinoma: Potential as a Diagnostic and Prognostic Marker.

    Terra X, Ceperuelo-Mallafré V, Merma C, Benaiges E, Bosch R, Castillo P, Flores JC, León X, Valduvieco I, Basté N, Cámara M, Lejeune M, Gumà J, Vendrell J, Vilaseca I, Fernández-Veledo S, Avilés-Jurado FX. Cancers (Basel). 2021;13:1653. PMID: 33916314

    DOI: 10.3390/cancers13071653

    Measuring Tracheotomy Risk in Patients with COVID-19-Time to Look Beyond Surgery and Surgeons-Reply.

    Avilés-Jurado FX, Vilaseca I. JAMA Otolaryngol Head Neck Surg. 2021 Jul 1;147(7):679-680. doi: 10.1001/jamaoto.2021.0552. PMID: 33885721

    DOI: 10.1001/jamaoto.2021.0552

    Transoral laser microsurgery in locally advanced laryngeal cancer: Prognostic impact of anterior versus posterior compartments.

    Vilaseca I, Aviles-Jurado FX, Valduvieco I, Berenguer J, Grau JJ, Baste N, Muxí Á, Castillo P, Lehrer E, Jordana M, Ramírez-Ruiz RD, Costa JM, Oleaga L, Bernal-Sprekelsen M. Head Neck. 2021;43:3832-3842. PMID: 34569120

    DOI: 10.1002/hed.26878

    The aspartate aminotransaminase/alanine aminotransaminase (De Ritis) ratio predicts sensitivity to radiotherapy in head and neck carcinoma patients.

    Sansa A, Venegas MDP, Valero C, Pardo L, Avilés-Jurado FX, Terra X, Quer M, León X. Head Neck. 2021 ;43:2091-2100. PMID: 3367509

    DOI: 10.1002/hed.26673

    Outcome of 1890 tracheostomies for critical COVID-19 patients: a national cohort study in Spain.

    Martin-Villares C, Perez Molina-Ramirez C, Bartolome-Benito M, Bernal-Sprekelsen M; COVID ORL ESP Collaborative Group (*). Eur Arch Otorhinolaryngol. 2021;278:1605-1612. PMID: 32749607

    DOI: 10.1007/s00405-020-06220-3

    Circulating microRNAs modulating glycolysis as non-invasive prognostic biomarkers of HNSCC.

    Avilés-Jurado FX, Muñoz C, Meler C, Flores JC, Gumà J, Benaiges E, Mora J, Camacho M, León X, Vilaseca I, Terra X. Eur Arch Otorhinolaryngol. 2021 May;278(5):1585-1594. PMID: 32737645

    DOI: 10.1007/s00405-020-06240-z

    Timing, Complications, and Safety of Tracheotomy in Critically Ill Patients with COVID-19.

    Avilés-Jurado FX, Prieto-Alhambra D, González-Sánchez N, de Ossó J, Arancibia C, Rojas-Lechuga MJ, Ruiz-Sevilla L, Remacha J, Sánchez I, Lehrer-Coriat E, López-Chacón M, Langdon C, Guilemany JM, Larrosa F, Alobid I, Bernal-Sprekelsen M, Castro P, Vilaseca I. JAMA Otolaryngol Head Neck Surg. 2020;147:1-8.

    DOI: 10.1001/jamaoto.2020.3641

    Predictive capacity of IL-8 expression in head and neck squamous carcinoma patients treated with radiotherapy or chemoradiotherapy.

    León X, García J, Farré N, Majercakova K, Avilés-Jurado FX, Quer M, Camacho M. Acta Otorrinolaringol Esp (Engl Ed). 2020 Sep 21:S0001-6519(20)30146-1. PMID: 32972719

    DOI: 10.1016/j.otorri.2020.05.003

    Transoral reconstruction of oropharyngeal tumors. The Hospital Clínic algorithm.

    Avilés-Jurado FX, Vilaseca I. JPRAS Open. 2020 Mar 21;24:25-31.. PMID: 32300634

    DOI: 10.1016/j.jpra.2020.03.003

    Consensus document of the Spanish Society of Intensive and Critical Care Medicine and Coronary Units (SEMICYUC), the Spanish Society of Otorhinolaryngology and Head and Neck Surgery (SEORL-CCC) and the Spanish Society of Anesthesiology and Resuscitation (SEDAR) on tracheotomy in patients with COVID-19 infection.

    Martín Delgado MC, Avilés-Jurado FX, Álvarez Escudero J, Aldecoa Álvarez-Santuyano C, de Haro López C, Díaz de Cerio Canduela P, Ferrandis Perepérez E, Ferrando Ortolá C, Ferrer Roca R, Hernández Tejedor A, López Álvarez F, Monedero Rodríguez P, Ortiz Suñer A, Parente Arias P, Planas Roca A, Plaza Mayor G, Rascado Sedes P, Sistiaga Suárez JA, Vera Ching C, Villalonga Vadell R, Bernal-Sprekelsen M. Med Intensiva (Engl Ed). 2020;44:493-499.

    DOI: 10.1016/j.redar.2020.05.001

    Factors of local recurrence and organ preservation with transoral laser microsurgery in laryngeal carcinomas; CHAID decision-tree analysis

    Vilaseca I, Nogués A, Avilés-Jurado FX, Berenguer J, Grau JJ, Verger E et al. Head Neck 2019;41:756-764. PMID 30521676. IF 3.376. Otorhinolaryngology, 1/42. Science Citation Index (SCI)

    DOI: 10.1002/hed.25422

    Intra and interobserver agreement of Narrow Band Imaging for the detection of head and neck tumors.

    Nogués-Sabaté A, Avilés-Jurado FX, Ruiz-Sevilla L, Lehrer E, Santamaría-Gadea A, Valls-Mateus M, Vilaseca I. Eur Arch Oto-Rhino-Laryngol. 2018;275:2349-2354. PMID 30019190. IF 1.545 Àrea i posició dins d’ella: Otorhinolaryngology 18/43. Science Citation Index (SCI)

    DOI: 10.1007/s00405-018-5063-8

    Narrow band imaging for head and neck malignancies: Lessons learned from mistakes.

    Valls-Mateus M, Nogués-Sabaté A, Blanch JL, Bernal-Sprekelsen M, Avilés-Jurado FX, Vilaseca I. Head Neck. 2018;40:1164-1173. PMID 29385299. IF 3.376. Àrea i posició dins d’ella: Otorhinolaryngology, 1/43. Science Citation Index (SCI)

    DOI: 10.1002/hed.25088

    Prognostic value of CD45 transcriptional expression in head and neck cancer

    Camacho M, Agüero A, Sumarroca A, López L, Pavón MÁ, Avilés-Jurado FX, García J, Quer M, León X. Eur Arch Otorhinolaryngol. 2018;275:225-232. PMID  29177949 IF 1.545. Otorhinolaryngology 18/43. Science Citation Index (SCI).

    DOI: 10.1007/s00405-017-4806-2

    Prognostic relevance of insulin resistance on disease-free survival in head and neck squamous cell carcinomas: Preliminary results.

    Avilés-Jurado FX; Flores JC; Gumà J; Ceperuelo-Mallafré V; Casanova-Marqués R; Gómez D et al. Títol: Head and Neck. 2017;39:2501-2511.  Corresponding author.  PMID 28963801. IF 2.471 Àrea i posició dins d’ella: otorhinolaryngology, 9/41. Science Citation Index (SCI)

    DOI: 10.1002/hed.24919

    Usefulness of office examination with narrow band imaging for the diagnosis of head and neck squamous cell carcinoma and follow-up of premalignant lesions.

    Vilaseca, I; Valls-Mateus, M; Nogues, A; Lehrer, E; Lopez-Chacon, M; Aviles-Jurado, FX; Blanch, JL; Bernal-Sprekelsen, M. Head & Neck 2017.39;1854-1863. IF 2.471. PMID: 28640478 Otorhinolaryngology 9/41. Science Citation Index (SCI)

    DOI: 10.1002/hed.24849

    Risk Factors for Noninvasive Ventilation Failure in Critically Ill Subjects With Confirmed Influenza Infection

    Rodríguez A, Ferri C, Martin-Loeches I, Díaz E, Masclans JR, Gordo F, Sole-Violán J, Bodí M, Avilés-Jurado FX, Trefler S et al.. Respir Care. 2017;62:1307-1315. IF: 0.751. PMID 28698265. Critical care 26/50. Science Citation Index (SCI)

    DOI: 10.4187/respcare.05481

    Procalcitonin (PCT) levels for ruling-out bacterial coinfection in ICU patients with influenza: A CHAID decision-tree analysis

    Rodríguez, A.H.; Avilés-Jurado, F.X.; Díaz, E.; Schuetz, P.; Trefler, S.I.; Solé-Violán, J.; Cordero, L et al.. Journal of Infection 2016;72:143-151. PMID 26702737 IF 4.201  Infectious diseases, 16/84. Science Citation Index (SCI)

    DOI: 10.1016/j.jinf.2015.11.007

    External validation of sTWEAK as a prognostic noninvasive biomarker for head and neck squamous cell carcinoma.

    Terra X, Gómez D, García-Lorenzo J, Flores JC, Figuerola E, Mora J, Chacón MR, Quer M, Camacho M, León X, Avilés-Jurado FX. Head and Neck. 2016;38:1358-1363  Corresponding author. IF 3.376 Àrea i posició dins d’ella: otorhinolaryngology, 1/43. Science Citation Index (SCI)

    DOI: 10.1002/hed.24227

    Low blood levels of sTWEAK are related to locoregional failure in head and neck cancer

    Avilés-Jurado FX; Terra X; Gómez D;  Flores JC; Raventós A; Maymó E et al.. Eur Arch Oto-Rhino-Laryngol 2015;272:1733-1741 Corresponding author. PMID 24858806. IF 1.545 Àrea i posició dins d’ella: Otorhinolaryngology 18/43. Science Citation Index (SCI)

    DOI: 10.1007/s00405-014-3095-2

    Prostacyclin-synthase expression in head and neck carcinoma patients and its prognostic value in the response to radiotherapy.

    Camacho, M., Piñeiro, Z., Alcolea, S., García, J., Balart, J., Terra, X., Avilés-Jurado, F.-X., Soler, M., Quer, M., León, X., Vila, L. Journal of Pathology 2015.235;125-135. IF 7.381 oncology, 18/213; pathology, 3/78. Science Citation Index (SCI)

    DOI: 10.1002/path.4453

    Prognostic factors in head and neck squamous cell carcinoma: Comparison of CHAID decision trees technology and cox analysis

    Avilés-Jurado, F.X.; León, X. Head and Neck. 2013;35:877-883  Corresponding author. IF 3.006 Àrea i posició dins d’ella: otorhinolaryngology, 1/ 43. Science Citation Index (SCI)

    DOI: 10.1002/hed.23058

    Overexpression of the nuclear factor-kappa B (p65) in association with local failure in patients with head and neck carcinoma undergong radiotherapy or chemoradiotherapy.

    Quintana, A.; Avilés, F.X.; Terra, X.; Alcolea, S.; Camacho, M.; Quer, M.; Vila, L.; León, X. Head and Neck. 2013;35:370-375  PMID 22422610 IF 3.006 Àrea i posició dins d’ella: otorhinolaryngology, 1/ 43. Science Citation Index (SCI)

    DOI: 10.1002/hed.22979

    Comparison of Chi Squared Automatic Interaction Detection Classification Trees vs TNM Classification for Patients with Head and Neck Squamous Cell Carcinoma

    Avilés-Jurado, F.X; Terra, X.; Figuerola, E.; Quer, M.; León, X. JAMA Archives of Otolaryngology-Head & Neck Surgery. 2012;138:272-279. Corresponding autor. PMID 22431872 IF 3.5. otorhinolaryngology 2/ 41. Science Citation Index (SCI)

    DOI: 10.1001/archoto.2011.1448

    Interaction between head and neck squamous cell carcinoma cells and fibroblasts in the biosynthesis of PGE2.

    Alcolea S, Antón R, Camacho M, Soler M, Alfranca A, Avilés-Jurado FX et al. J Lipid Res. 2012;53:630-42. PMID: 22308510.

    DOI: 10.1194/jlr.M019695

    Angioedema ACE inhibitor

    Avilés Jurado FX, Planas Real K, Tobed Secall M, Doménech Vadillo E, Pobo Peris A, Figuerola Massana E.. Med Clin (Barc). 2010;134:664. IF 1.231. Medicine general and internal Q3. PMID: 19712942 Science Citation Index (SCI)

    DOI: 10.1016/j.medcli.2009.06.026

Membres De L’equip

  • Responsable de grup

    • Dr. F. Xavier Avilés Jurado
  • Investigadora senior

    • Ximena Terra Barbadora
  • Laringòloga

    • Carla Vanessa Merma Linares
  • Laringòleg

    • Joan Carles Flores Martín